Eton Pharmaceutcials, Inc. Common Stock ETON
$61.73
+4.88%
at last close
Market Cap$1.68 billion
P/E Ratio—
Div Yield—
Volume1.28M
52-Week Range
$13.76$62.87
Analyst Ratings
- Consensus
- Buy — 4 Buy · 0 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $67.50 (+9.3% upside)
Key Stats
- Today's Range
- $56.65 – $62.87
- 50-Day Range
- $28.41 – $62.87
- 52-Week Range
- $13.76 – $62.87
- Volume
- 1.28 million shs
- Average Volume
- 606K shs
- Market Cap
- $1.68 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 36.11
- Price / Sales
- 15.93
Short Interest
- Short Interest
- 0.21%
- Days to Cover
- 1.01
Financials (TTM)
- Revenue
- $105.59 million
- Net Income
- $12.69 million
- Net Margin
- 12.02%
- Return on Equity
- 27.24%
- Debt-to-Equity
- —
About Eton Pharmaceutcials, Inc. Common Stock
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Related Stocks
Compare head-to-head: ETON vs LLY·ETON vs JNJ·ETON vs ABBV·ETON vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.